Abstract
Craniopharyngiomas are tumors usually found in the region of the infundibulum, although they can develop anywhere along an axis from the nasopharynx to the third ventricle. They comprise approximately 5–10 % of pediatric brain tumors and present with signs and symptoms referable to their location, including visual loss, hormonal disturbances, hydrocephalus, and headache. The broad spectrum of management strategies employed in the treatment of these tumors—including surgical resection, radiation, and intratumoral delivery of chemotherapeutic agents or radioisotopes—underscores the difficulty of achieving successful cures with acceptable morbidity and has fostered considerable controversy among physicians involved in the care of children with these lesions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
[Craniopharyngioma in children. 41st annual congress of the French Society of Neurosurgery. Lisbon, Portugal, 4–7 June 1991]. Neurochirurgie 1991;37(Suppl 1):1–174. French.
Lindholm J, Nielsen EH. Craniopharyngioma: historical notes. Pituitary. 2009;12:352–9.
Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol. 1993;3:255–68.
Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109.
Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61:215–25 (discussion 26–9).
Jane JA Jr, Laws ER. Craniopharyngioma. Pituitary. 2006;9:323–6.
Kanter AS, Sansur CA, Jane JA Jr, Laws ER Jr. Rathke’s cleft cysts. Front Horm Res. 2006;34:127–57.
Pettorini BL, Frassanito P, Caldarelli M, Tamburrini G, Massimi L, Di Rocco C. Molecular pathogenesis of craniopharyngioma: switching from a surgical approach to a biological one. Neurosurg Focus. 2010;28:E1.
Donovan JL, Nesbit GM. Distinction of masses involving the sella and suprasellar space: specificity of imaging features. AJR Am J Roentgenol. 1996;167:597–603.
Zada G, Lin N, Ojerholm E, Ramkissoon S, Laws ER. Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships. Neurosurg Focus. 2010;28:E4.
Miller DC. Pathology of craniopharyngiomas: clinical import of pathological findings. Pediatr Neurosurg. 1994;21(Suppl 1):11–7.
Crotty TB, Scheithauer BW, Young WF Jr, et al. Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg. 1995;83:206–14.
Weiner HL, Wisoff JH, Rosenberg ME, et al. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery. 1994;35:1001–10 (discussion 10–1).
Smith ER, Manfredi M, Scott RM, Black PM, Moses MA. A recurrent craniopharyngioma illustrates the potential usefulness of urinary matrix metalloproteinases as noninvasive biomarkers: case report. Neurosurgery. 2007;60:E1148–9 (discussion E9).
Smith ER, Zurakowski D, Saad A, Scott RM, Moses MA. Urinary biomarkers predict brain tumor presence and response to therapy. Clin Cancer Res. 2008;14:2378–86.
Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg. 1998;89:547–51.
Samii M, Tatagiba M. Surgical management of craniopharyngiomas: a review. Neurol Med Chir (Tokyo). 1997;37:141–9.
Scott RM. Craniopharyngioma: a personal (Boston) experience. Childs Nerv Syst. 2005;21:773–7.
Karavitaki N, Brufani C, Warner JT, et al. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf). 2005;62:397–409.
Feletti A, Marton E, Mazzucco GM, Fang S, Longatti P. Amaurosis in infancy due to craniopharyngioma: a not-exceptional but often misdiagnosed symptom. Neurosurg Focus. 2010;28:E7.
Sanford RA, Muhlbauer MS. Craniopharyngioma in children. Neurol Clin. 1991;9:453–65.
Samii M, Bini W. Surgical treatment of craniopharyngiomas. Zentralbl Neurochir. 1991;52:17–23.
Smith MM, Strottmann JM. Imaging of the optic nerve and visual pathways. Semin Ultrasound CT MR. 2001;22:473–87.
Wisoff JH. Craniopharyngioma. J Neurosurg Pediatr. 2008;1:124–5 (discussion 5).
Wisoff JH. Surgical management of recurrent craniopharyngiomas. Pediatr Neurosurg 1994;21(Suppl 1):108–13.
Sanford RA. Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery. Pediatr Neurosurg. 1994;21(Suppl 1):39–43.
Merchant TE, Kiehna EN, Sanford RA, et al. Craniopharyngioma: the St. Jude Children’s Research Hospital experience 1984–2001. Int J Radiat Oncol Biol Phys. 2002;53:533–42.
Hoffman HJ, De Silva M, Humphreys RP, Drake JM, Smith ML, Blaser SI. Aggressive surgical management of craniopharyngiomas in children. J Neurosurg. 1992;76:47–52.
Elliott RE, Hsieh K, Hochm T, Belitskaya-Levy I, Wisoff J, Wisoff JH. Efficacy and safety of radical resection of primary and recurrent craniopharyngiomas in 86 children. J Neurosurg Pediatr. 2010;5:30–48.
Ullrich NJ, Robertson R, Kinnamon DD, et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology. 2007;68:932–8.
Yang I, Sughrue ME, Rutkowski MJ, et al. Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus. 2010;28:E5.
Campbell PG, McGettigan B, Luginbuhl A, Yadla S, Rosen M, Evans JJ. Endocrinological and ophthalmological consequences of an initial endonasal endoscopic approach for resection of craniopharyngiomas. Neurosurg Focus. 2010;28:E8.
Curtis J, Daneman D, Hoffman HJ, Ehrlich RM. The endocrine outcome after surgical removal of craniopharyngiomas. Pediatr Neurosurg. 1994;21(Suppl 1):24–7.
Waber DP, Pomeroy SL, Chiverton AM, et al. Everyday cognitive function after craniopharyngioma in childhood. Pediatr Neurol. 2006;34:13–9.
Muller HL, Bruhnken G, Emser A, et al. Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma. Childs Nerv Syst. 2005;21:975–80.
Kim SK, Wang KC, Shin SH, Choe G, Chi JG, Cho BK. Radical excision of pediatric craniopharyngioma: recurrence pattern and prognostic factors. Childs Nerv Syst. 2001;17:531–6 (discussion 7).
Bulow B, Attewell R, Hagmar L, Malmstrom P, Nordstrom CH, Erfurth EM. Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. J Clin Endocrinol Metab. 1998;83:3897–904.
Elliott RE, Moshel YA, Wisoff JH. Minimal residual calcification and recurrence after gross-total resection of craniopharyngioma in children. J Neurosurg Pediatr. 2009;3:276–83.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Smith, E., Scott, R. (2014). Craniopharyngioma. In: Rahbar, R., Rodriguez-Galindo, C., Meara, J., Smith, E., Perez-Atayde, A. (eds) Pediatric Head and Neck Tumors. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8755-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8755-5_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8754-8
Online ISBN: 978-1-4614-8755-5
eBook Packages: MedicineMedicine (R0)